Breakingviews - Moderna success is a win for poorer countries
NEW YORK (Reuters Breakingviews) - Moderna’s success in producing what appears to be a highly effective Covid-19 vaccine is a win for everyone, but especially for poorer countries. The U.S. drug company’s achievement, and Pfizer’s before it, raises the odds that rivals will be able to do the same. The less scarce such drugs are, the sooner hard-hit emerging economies will gain access to them and the quicker their growth will rebound.
